These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Hypermineralcorticism syndrome secondary to topical application of 9-alpha-fluoroprednisolone (author's transl)]. Vasconez F, Pérez-Garcia R, Olivas E, Bolívar JE, Valderrábano F. Med Clin (Barc); 1980 Dec 15; 75(10):430-4. PubMed ID: 7464329 [Abstract] [Full Text] [Related]
5. [Arterial hypertension secondary to the application of 9-alpha-fluoroprednisolone ointments]. Arnal JM, Moneo MI, Loris C. An Esp Pediatr; 1987 Jan 15; 26(1):65-6. PubMed ID: 3826948 [No Abstract] [Full Text] [Related]
6. Pseudohyperaldosteronism due to application of an antihemorrhoid cream. Marin F, González Quintela A, Moya M, Suárez E, de Zárraga M. Nephron; 1989 Jan 15; 52(3):281-2. PubMed ID: 2739869 [Abstract] [Full Text] [Related]
12. [Severe hypopotassemia and rhabdomyolysis in a normotensive subject after use of a nasal spray containing 9-alpha-fluoroprednisolone]. Wu SC, Secchi MB, Mancarella S, Oltrona L, Bettazzi L, Sale M, Ambrosi B. Recenti Prog Med; 1989 Apr 15; 80(4):195-6. PubMed ID: 2762657 [Abstract] [Full Text] [Related]
13. Rhabdomyolysis, oedema and arterial hypertension: different syndromes related to topical use of 9-alpha-fluoroprednisolone. Lauzurica R, Bonal J, Bonet J, Romero R, Teixido J, Serra A, Caralps A. J Hum Hypertens; 1988 Oct 15; 2(3):183-6. PubMed ID: 3236321 [Abstract] [Full Text] [Related]